Molecular diagnostics of ocular diseases: The application of antibody microarray

Expert Review of Molecular Diagnostics

Volumn 12, Issue 6, 2012, Pages 629-643

  Izzotti, Alberto ^a   Centofanti, Marco ^b   Saccà, Sergio Claudio ^c  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

antibody microarray; blindness; cataract; glaucoma; ocular aqueous humor; oxidative stress; proteome; trabecular meshwork damage

Indexed keywords

ANTIBODY; CARBONATE DEHYDRATASE; GLUTATHIONE; MONOCLONAL ANTIBODY; PROTEOME; SUPEROXIDE DISMUTASE; THIOREDOXIN;

AMINO ACID SEQUENCE; ANTIBODY SPECIFICITY; APOPTOSIS; AQUEOUS HUMOR; BIOCHEMICAL COMPOSITION; BLADDER CANCER; BLOOD SAMPLING; BREAST CANCER; CATARACT; CELL JUNCTION; CILIARY BODY; COLON CANCER; COLUMN CHROMATOGRAPHY; CORNEA; DEGENERATION; DOWN REGULATION; DRY EYE; ENZYME LINKED IMMUNOSORBENT ASSAY; EYE DISEASE; FUNCTIONAL PROTEOMICS; HUMAN; IRIS; ISOELECTRIC POINT; LUNG CANCER; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; MICROARRAY ANALYSIS; MOLECULAR DIAGNOSIS; OPEN ANGLE GLAUCOMA; OPTIC NERVE; OXIDATIVE STRESS; PANCREAS CANCER; PATHOGENESIS; PROGNOSIS; PROLIFERATIVE RETINOPATHY; PROSTATE CANCER; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN PURIFICATION; RETINA; REVIEW; SJOEGREN SYNDROME; STOMACH CANCER; TISSUE HOMOGENATE; TRABECULAR MESHWORK; VITRECTOMY; WESTERN BLOTTING;

ANTIBODIES; EYE DISEASES; EYE PROTEINS; GLAUCOMA; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; PROTEIN ARRAY ANALYSIS; PROTEOME; PROTEOMICS;

EID: 84864612864     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/erm.12.57     Document Type: Review

References (49)

1. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br. J. Ophthalmol. 90, 262-267 (2006).
2. Saccà SC, Bolognesi C, Battistella A, Bagnis A, Izzotti A. Gene-environment interactions in ocular diseases. Mutat. Res. 667, 98-117 (2009).
3. De Flora S, Izzotti A. Modulation of genomic and postgenomic alterations in noncancer diseases and critical periods of life. Mutat. Res. 667, 15-26 (2009).
4. Izzotti A, Bagnasco M, Cartiglia C, Longobardi M, De Flora S. Proteomic analysis as related to transcriptome data in the lung of chromium(VI) treated rats. Int. J. Oncol. 24, 1513-1522 (2004).
5. Melton L. Proteomics in multiplex. Nature 429, 101-107 (2004).
6. Sanchez-Carbayo M, Socci ND, Lozano JJ, Haab BB, Cordon-Cardo C. Profiling bladder cancer using targeted antibody arrays. Am. J. Pathol. 168, 93-103 (2006).
7. Madoz-Gúrpide J, Cañamero M, Sanchez L, Solano J, Alfonso P, Casal JI. A proteomics analysis of cell signaling alterations in colorectal cancer. Mol. Cell. Proteomics 6, 2150-2164 (2007).
8. Ellmark P, Ingvarsson J, Carlsson A, Lundin BS, Wingren C, Borrebaeck CA. Identification of protein expression signatures associated with Helicobacter pylori infection and gastric adenocarcinoma using recombinant antibody microarrays. Mol. Cell. Proteomics 5, 1638-1646 (2006).
9. Hudelist G, Pacher-Zavisin M, Singer CF et al. Use of high-throughput protein array for profiling of differentially expressed proteins in normal and malignant breast tissue. Breast Cancer Res. Treat. 86, 281-291 (2004).
10. Carlsson A, Wingren C, Ingvarsson J et al. Serum proteome profiling of metastatic breast cancer using recombinant antibody microarrays. Eur. J. Cancer 44, 472-480 (2008).
11. Bohm D, Keller K, Boehm N et al. Antibody microarray analysis of the serum proteome in primary breast cancer patients. Cancer Biol. Ther. 12, 772-779 (2011).
12. Bartling B, Hofmann HS, Boettger T et al. Comparative application of antibody and gene array for expression profiling in human squamous cell lung carcinoma. Lung Cancer 49, 145-154 (2005).
13. Han MK, Oh YH, Kang J et al. Protein profiling in human sera for identification of potential lung cancer biomarkers using antibody microarray. Proteomics 9, 5544-5552 (2009).
14. Orchekowski R, Hamelinck D, Li L et al. Antibody microarray profiling reveals individual and combined serum proteins associated with pancreatic cancer. Cancer Res. 65, 11193-11202 (2005).
15. Shafer MW, Mangold L, Partin AW, Haab BB. Antibody array profiling reveals serum TSP-1 as a marker to distinguish benign from malignant prostatic disease. Prostate 67, 255-267 (2007).
16. Srivastava M, Eidelman O, Jozwik C et al. Serum proteomic signature for cystic fibrosis using an antibody microarrayplatform. Mol. Genet. Metab. 87, 303-310 (2006).
17. Chowdhury U, Madden BJ, Charlesworth MC, Fautsch MP. Proteome analysis of aqueous humor. Invest. Ophth. Vis. Sci. 51, 4921-4931 (2010).
18. Szodoray P, Alex P, Brun JG, Centola M, Jonsson R. Circulating cytokines in primary Sjögren's syndrome determined by a multiplex cytokine array system. Scand. J. Immunol. 59, 592-599 (2004).
19. Bennett KL, Funk M, Tschernutter M et al. Proteomic analysis of human cataract aqueous humour: Comparison of one-dimensional gel LCMS with two-dimensional LCMS of unlabelled and iTRAQ®-labelled specimens. J. Proteomics 74, 151-166 (2011).
20. Baussant T, Bougueleret L, Johnson A et al. Effective depletion of albumin using a new peptide-based affinity medium. Proteomics 5, 973-977 (2005).
21. Granger J, Siddiqui J, Copeland S, Remick D. Albumin depletion of human plasma also removes low abundance proteins including the cytokines. Proteomics 5, 4713-4718 (2005).
22. Richardson MR, Price MO, Price FW et al. Proteomic analysis of human aqueous humor using multidimensional protein identification technology. Mol. Vis. 15, 2740-2750 (2009).
23. Escoffier P, Paris L, Bodaghi B, Danis M, Mazier D, Marinach-Patrice C. Pooling aqueous humor samples: Bias in 2D-LC-MS/MS strategy? J. Proteome Res. 9, 789-797 (2010).
24. Yu J, Liu F, Cui SJ et al. Vitreous proteomic analysis of proliferative vitreoretinopathy. Proteomics 8, 3667-3678 (2008).
25. De Souza GA, Godoy LM, Mann M. Identification of 491 proteins in the tear fluid proteome reveals a large number of proteases and protease inhibitors. Genome Biol. 7, R72 (2006).
26. Missotten GS, Beijnen JH, Keunen JE, Bonfrer JM. Proteomics in uveal melanoma. Melanoma Res. 13, 627-629 (2003).
27. Duan X, Lu Q, Xue P et al. Proteomic analysis of aqueous humor from patients with myopia. Mol. Vis. 14, 370-377 (2008).
28. Funding M, Vorum H, Honore B, Nexo E, Ehlers N. Proteomic analysis of aqueous humor from patients with acute corneal rejection. Acta Ophthalmol. Scand. 83, 31-39 (2005).
29. Grus FH, Joachim SC, Sandmann S et al. Transthyretin and complex protein pattern in aqueous humor of patients with primary open-angle glaucoma. Mol. Vis. 14, 1437-1445 (2008).
30. Duan X, Xue P, Wang N, Dong Z, Lu Q, Yang F. Proteomic analysis of aqueous humor from patients with primary open angle glaucoma. Mol. Vis. 16, 2839-2846 (2010).
31. Izzotti A. Saccà SC, Longobardi MG, Cartiglia C. Proteome alterations in aqueous humor of glaucomatous patients. J. Prot. Res. 9, 4831-4838 (2010).
32. Izzotti A, Saccà SC, Longobardi M, Cartiglia C. Mitochondrial damage in the trabecular meshwork of patients with glaucoma. Arch. Ophth. 128, 724-730 (2010).
33. Izzotti A, Longobardi MG, Cartiglia C, Saccà SC. Mitochondrial damage in the trabecular meshwork occurs only in primary open-angle glaucoma and in pseudoexfoliative glaucoma. Plos ONE 6, e14567 (2010).
34. Mocan MC, Dikmetas O, Irkec M. Serum C-reactive protein levels in exfoliation syndrome and exfoliative glaucoma. Eye 25, 1383-1384 (2011).
35. Huang P, Qi Y, Xu YS et al. Serum cytokine alteration is associated with optic neuropathy in human primary open angle glaucoma. J. Glaucoma. 19, 324-330 (2010).
36. Engin KN, Yemişci B, Yiǧit U, Aǧaçhan A, Coşkun C. Variability of serum oxidative stress biomarkers relative to biochemical data and clinical parameters of glaucoma patients. Mol. Vis. 16, 1260-1271 (2010).
37. Yuki K, Murat D, Kimura I, Ohtake Y, Tsubota K. Reduced-serum vitamin C and increased uric acid levels in normal-tension glaucoma. Graefes Arch. Clin. Exp. Ophthalmol. 248, 243-248 (2010).
38. Chen HY, Chang YC, Chen WC, Lane HY. Association between plasma endothelin-1 and severity of different types of glaucoma. J. Glaucoma doi:10.1097/ IJG.0b013e31822e8c65 (2011) (Epub ahead of print).
39. Dervan EW, Chen H, Ho SL et al. Protein macroarray profiling of serum autoantibodies in pseudoexfoliation glaucoma. Invest. Ophthalmol. Vis. Sci. 51, 2968-2975 (2010).
40. Wingren C, Borrebaeck CA. Antibody microarray analysis of directly labeled complex proteomes. Curr. Opin. Biotechnol. 19, 55-61 (2008).
41. Ingvarsson J, Lindstedt M, Borrebaeck CA, Wingren C. One-step fractionation of complex proteomes enables detection of low abundant analytes using antibody-based microarrays. J. Proteome Res. 5, 170-176 (2006).
42. Kusnezow W, Banzon V, Schröder C et al. Antibody microarray-based profiling of complex specimens: Systematic evaluation of labeling strategies. Proteomics 7, 1786-1799 (2007).
43. Wingren C, Borrebaeck CA. Antibody microarrays: Current status and key technological advances. OMICS 10, 411-427 (2006).
44. Borrebaeck CAK, Wingren C. Design of high-density antibody microarrays for disease proteomics: Key technological issues. J. Proteomics 72, 928-935 (2009).
45. Izzotti A, Saccà SC, Longobardi MG, Cartiglia C. Susceptibility of different ocular tissues to oxidative damage and its relevance to the pathogenesis of glaucoma. Invest. Ophthalmol. Vis. Sci. 50, 5251-5258 (2009).
46. Izzotti A, Saccà SC, Cartiglia C, De Flora S. Oxidative DNA damage in the eye of glaucoma patients. Am. J. Med. 114, 638-646 (2003).
47. Christen R, Pache M, Teuchner B, Meyer P, Prante C, Flammer J. Iris transillumination defects in patients with primary open angle glaucoma. Eur. J. Ophthalmol. 13, 365-369 (2003).
48. Izzotti A, Bagnasco M, Cartiglia C et al. Chemoprevention of genome, transcriptome, and proteome alterations induced by cigarette smoke in rat lung. Eur. J. Cancer 41, 1864-1874 (2005).
49. Haymes SA, LeBlanc RP, Nicolela MT, Chiasson LA, Chauhan BC. Glaucoma and on-road driving performance. Invest. Ophthalmol. Vis. Sci. 49, 3035-3041 (2008).